291
TÍTULO: The prevalence and importance of frailty in heart failure with reduced ejection fraction – an analysis of PARADIGM‐HF and ATMOSPHERE  Full Text
AUTORES: Pooja Dewan; Alice Jackson; Pardeep S Jhund; Li Shen; João Pedro Ferreira ; Mark C Petrie; William T Abraham; Akshay S Desai; Kenneth Dickstein; Lars Køber; Milton Packer; Jean L Rouleau; Scott D Solomon; Karl Swedberg; Michael R Zile; John J.V McMurray;
PUBLICAÇÃO: 2020, FONTE: European Journal of Heart Failure, VOLUME: 22, NÚMERO: 11
INDEXADO EM: CrossRef: 95
292
TÍTULO: Timing of randomization after an acute coronary syndrome in patients with type 2 diabetes mellitus  Full Text
AUTORES: Malik Elharram; Abhinav Sharma; William White; George Bakris; Patrick Rossignol; Cyrus Mehta; João Pedro Ferreira ; Faiez Zannad;
PUBLICAÇÃO: 2020, FONTE: American Heart Journal, VOLUME: 229
INDEXADO EM: CrossRef: 5
293
TÍTULO: Use of the Win Ratio in Cardiovascular Trials  Full Text
AUTORES: João Pedro Ferreira ; Pardeep S Jhund; Kévin Duarte; Brian L Claggett; Scott D Solomon; Stuart Pocock; Mark C Petrie; Faiez Zannad; John J.V McMurray;
PUBLICAÇÃO: 2020, FONTE: JACC: Heart Failure, VOLUME: 8, NÚMERO: 6
INDEXADO EM: CrossRef: 43
294
TÍTULO: Visit-to-visit blood pressure variation and outcomes in heart failure with reduced ejection fraction: findings from the Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms trial
AUTORES: Luca Monzo; João Pedro Ferreira ; Paula Abreu; Annette Szumski; Michael Böhm; John J.V McMurray; Bertram Pitt; Karl Swedberg; Dirk J van Veldhuisen; Nicolas Girerd; John Vincent; Faiez Zannad; Patrick Rossignol;
PUBLICAÇÃO: 2020, FONTE: Journal of Hypertension, VOLUME: 38, NÚMERO: 3
INDEXADO EM: CrossRef: 12
295
TÍTULO: A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial
AUTORES: Mandeep R Mehra; Muthiah Vaduganathan; Min Fu; João Pedro Ferreira ; Stefan D Anker; John G F Cleland; Carolyn S P Lam; Dirk J van Veldhuisen; William M Byra; Theodore E Spiro; Hsiaowei Deng; Faiez Zannad; Barry Greenberg;
PUBLICAÇÃO: 2019, FONTE: European Heart Journal, VOLUME: 40, NÚMERO: 44
INDEXADO EM: CrossRef: 71
296
TÍTULO: Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, beta-blockers or both in incident end-stage renal disease patients without cardiovascular disease: a propensity-matched longitudinal cohort study
AUTORES: Ferreira, JP ; Couchoud, C; Gregson, J; Tiple, A; Glowacki, F; London, G; Agarwal, R; Rossignol, P;
PUBLICAÇÃO: 2019, FONTE: NEPHROLOGY DIALYSIS TRANSPLANTATION, VOLUME: 34, NÚMERO: 7
INDEXADO EM: Scopus WOS CrossRef: 4
297
TÍTULO: Balancing Benefits and Risks of Spironolactone in HFpEF and Chronic Kidney Disease Patients  Full Text
AUTORES: Patrick Rossignol; João Pedro Ferreira ;
PUBLICAÇÃO: 2019, FONTE: JACC: Heart Failure, VOLUME: 7, NÚMERO: 1
INDEXADO EM: CrossRef: 3
298
TÍTULO: Bioprofiles and mechanistic pathways associated with Cheyne-Stokes respiration: insights from the SERVE-HF trial  Full Text
AUTORES: João Pedro Ferreira ; Kévin Duarte; Holger Woehrle; Martin R Cowie; Christiane Angermann; Marie-Pia d’Ortho; Erland Erdmann; Patrick Levy; Anita K Simonds; Virend K Somers; Helmut Teschler; Karl Wegscheider; Emmanuel Bresso; Marie Dominique-Devignes; Patrick Rossignol; Wolfgang Koenig; Faiez Zannad;
PUBLICAÇÃO: 2019, FONTE: Clinical Research in Cardiology, VOLUME: 109, NÚMERO: 7
INDEXADO EM: CrossRef: 5
299
TÍTULO: Cardiovascular and non‐cardiovascular death distinction: the utility of troponin beyond N‐terminal pro‐B‐type natriuretic peptide. Findings from the BIOSTAT‐CHF study  Full Text
AUTORES: João Pedro Ferreira ; Wouter Ouwerkerk; Jasper Tromp; Leong Ng; Kenneth Dickstein; Stefan Anker; Gerasimos Filippatos; John G Cleland; Marco Metra; Dirk J Veldhuisen; Adriaan A Voors; Faiez Zannad;
PUBLICAÇÃO: 2019, FONTE: European Journal of Heart Failure, VOLUME: 22, NÚMERO: 1
INDEXADO EM: CrossRef: 15
300
TÍTULO: Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF study. 6MWT in heart failure  Full Text
AUTORES: Ferreira, JP ; Metra, M; Anker, SD; Dickstein, K; Lang, CC; Ng, L; Samani, NJ; Cleland, JG; van Veldhuisen, DJ; Voors, AA; Zannad, F;
PUBLICAÇÃO: 2019, FONTE: EUROPEAN JOURNAL OF HEART FAILURE, VOLUME: 21, NÚMERO: 2
INDEXADO EM: Scopus WOS CrossRef: 27
Página 30 de 39. Total de resultados: 385.